- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2018
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/11231
| Title: | Isoniazid monoresistantance - impact on treatment outcomes in patients with pulmonary tuberculosis |
| Authors: | Mironov, Tatiana
Donica, Ana |
| Keywords: | susceptible TB;treatment outcomes;treatment regimens |
| Issue Date: | 2018 |
| Publisher: | MedEspera |
| Citation: | MIRONOV, Tatiana, DONICA, Ana. Isoniazid monoresistantance - impact on treatment outcomes in patients with pulmonary tuberculosis. In: MedEspera: the 7th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2018, p. 84-85. |
| Abstract: | Introduction. Isoniazid monoresistance is the most common type of single TB drug resistance
worldwide. There is no strong evidence regarding the best treatment regimens in this group of
patients. |
| URI: | https://medespera.asr.md/wp-content/uploads/Abastract-Book-2018.pdf
http://repository.usmf.md/handle/20.500.12710/11231 |
| Appears in Collections: | MedEspera 2018
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|
